FIELD: pharmaceuticals.
SUBSTANCE: present invention relates to a pharmaceutical composition having improved stability, which contains palonosetron as an active ingredient.
EFFECT: composition according to the present invention can substantially provide storage stability without use of EDTA, unlike known inventions.
3 cl, 5 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| LIQUID COMPOSITION STABILIZING BOTULINUM TOXIN | 2019 |
|
RU2812790C2 |
| LIQUID COMPOSITION OF LONG-ACTING INSULIN AND INSULINOTROPIC PEPTIDE | 2013 |
|
RU2643766C2 |
| PHARMACEUTICAL COMPOSITION OF ANTITUMOR ACTIVITY (VERSIONS) AND METHOD FOR ITS OBTAINING (VERSIONS) | 1999 |
|
RU2201759C2 |
| LIQUID FORMULATION OF LONG-ACTING INSULIN CONJUGATE | 2013 |
|
RU2670270C2 |
| STABILIZED PEMETREXEDE COMPOSITION | 2014 |
|
RU2636783C2 |
| COMPOSITION FOR PREVENTION, RELIEF OF SYMPTOMS, OR TREATMENT OF NEURODEGENERATIVE DISEASES, CONTAINING PEDIOCOCCUS INOPINATUS | 2020 |
|
RU2791695C2 |
| LOXOPROFEN-CONTAINING PHARMACEUTICAL COMPOSITION FOR INTRAMUSCULAR INJECTIONS | 2001 |
|
RU2232572C2 |
| FORMULATIONS FOR PARENTERAL DELIVERY OF COMPOUNDS AND USING THEM | 2007 |
|
RU2539387C2 |
| COMPOSITIONS CONTAINING APOMORPHINE AND ORGANIC ACIDS, AND USING THEM | 2013 |
|
RU2688672C2 |
| AGENT AND FOOD STUFF FOR PREVENTION/SUPPRESSION OF FUNCTIONAL DYSPEPSIA | 2005 |
|
RU2407524C2 |
